MedGenome launches genetic test to diagnose FSHD1
For the first time, Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) test has been launched by MedGenome Laboratory in India.
Source: freepressjournal.in
Stay updated with breaking news from Genome Mapping Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For the first time, Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) test has been launched by MedGenome Laboratory in India.
FSHD1 affects approximately 1 in 20,000 individuals worldwide, with symptoms typically starting in early adulthood